At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
COSM COSMOS HEALTH INC
Trading 06-05 11:30:07 EDT
0.2583
-0.0126
-4.65%
High0.2799Low0.2559Vol1.04M
Open0.2775D1 Closing0.2709Amplitude8.86%
Mkt Cap15.49MTradable Cap11.90MTotal Shares59.96M
T/O276.73KT/O Rate2.26%Tradable Shares46.05M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
GlobeNewswire  ·  21:25
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
Cosmos Health secures EU-wide distribution for Sky Premium Life via Skroutz
Reuters  ·  03:57
Cosmos Health secures EU-wide distribution for Sky Premium Life via Skroutz
Cosmos Health - Identifies $20 Mln in Non-Core Assets for Potential Monetization
THOMSON REUTERS  ·  06-04 21:25
Cosmos Health - Identifies $20 Mln in Non-Core Assets for Potential Monetization
Cosmos Health explores monetizing about $20 million in non-core assets to fund acquisitions or cut debt
Reuters  ·  06-04 21:25
Cosmos Health explores monetizing about $20 million in non-core assets to fund acquisitions or cut debt
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
GlobeNewswire  ·  06-04 21:25
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
Cosmos Health says it sees no business reason for recent share price decline
Reuters  ·  06-02
Cosmos Health says it sees no business reason for recent share price decline
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang With No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline
THOMSON REUTERS  ·  06-02
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang With No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline
Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657
GlobeNewswire  ·  06-01
Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657
BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029
Reuters  ·  05-26
BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029
Cosmos Health forecasts 2029 revenue of $200.6 million
Reuters  ·  05-26
Cosmos Health forecasts 2029 revenue of $200.6 million
Cosmos Health- Projects 2029 Stockholders' Equity of $92.3 Mln & per-Share Value Creation With $0.73 EPS
THOMSON REUTERS  ·  05-26
Cosmos Health- Projects 2029 Stockholders' Equity of $92.3 Mln & per-Share Value Creation With $0.73 EPS
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted Ebitda by 2029 — Building an Innovative, High-Margin Healthcare Platform With Strong Cash Generation
THOMSON REUTERS  ·  05-26
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted Ebitda by 2029 — Building an Innovative, High-Margin Healthcare Platform With Strong Cash Generation
Cosmos Health Inc - Expects Profitability in 2027, Net Income $31 Mln by 2029
THOMSON REUTERS  ·  05-26
Cosmos Health Inc - Expects Profitability in 2027, Net Income $31 Mln by 2029
Cosmos Health announces annual shareholder meeting
Reuters  ·  05-23
Cosmos Health announces annual shareholder meeting
Cosmos Health says 4,874,126 Series B warrants expire unexercised
Reuters  ·  05-22
Cosmos Health says 4,874,126 Series B warrants expire unexercised
Cosmos Health Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $17.928M Miss $21.893M Estimate
Benzinga  ·  05-21
Cosmos Health Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $17.928M Miss $21.893M Estimate
Cosmos Health Q1 FY26 net loss widens to $2.81 million; revenue rises 30.7% to $17.93 million
Reuters  ·  05-21
Cosmos Health Q1 FY26 net loss widens to $2.81 million; revenue rises 30.7% to $17.93 million
BRIEF-Cosmos Health Q1 Revenue USD 17.9 Million
Reuters  ·  05-21
BRIEF-Cosmos Health Q1 Revenue USD 17.9 Million
Cosmos Health Q1 Operating Expenses USD 3.57 Million
THOMSON REUTERS  ·  05-21
Cosmos Health Q1 Operating Expenses USD 3.57 Million
Cosmos Health delays filing Q1 10-Q after XBRL, information compilation delays
Reuters  ·  05-16
Cosmos Health delays filing Q1 10-Q after XBRL, information compilation delays

Introduction

Company Name.
COSMOS HEALTH INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Issue price:
--